Category: Corporate NewsBy adminDecember 20, 2022 Author: admin https://ramedapharma-ir.com Post navigationPreviousPrevious post:Disclosure regarding Rameda acquiring exclusive rights for the distribution and marketing of “Physiomer” in EgyptNextNext post:Disclosure to EGX on BOD minutesRelated PostsRameda Announces New Chairman and Additions to its Board of DirectorsJune 3, 2026Rameda Initiates First Acquisition of 2025July 7, 2025Record Dividend Distribution DisclosureJuly 7, 2025Rameda One-Pager 1Q25May 13, 2025Earnings Release One-Pager 4Q24March 10, 2025Earning Release One Pager 3Q24November 14, 2024
